LIFE: Registration of new share capital

Bergen, 03 May 2022

Reference is made to the stock exchange announcement by Lifecare AS (the
"Company") on 20 April 2022 regarding the share issue resolved by the board of
directors as part of the previously agreed consideration from Lifecare AS to
acquire Lifecare Laboratories GmbH (formely named Pfützner Science and Health
GmbH). The share capital increase has now been registered with the Norwegian
Register of Business Enterprises (Nw. Foretaksregisteret). The new share capital
of the Company is NOK 39,896,409.20, divided into 99,741,023 shares, each with a
nominal value of NOK 0.4 


This is Lifecare 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE).

Further information: Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. This stock exchange announcement was
published by Kine Hereid, Investor Relations at Lifecare AS, on 03 May 2022 at
16:00 CET.